The Annexure

News to 16 October 2026 ·

Desk›Healthcare› Granules India Ltd

Granules India Ltd

BSE 532482 · NSE GRANULES · ISIN INE101D01020 · Group A · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹832.55

+0.41%

BSE close, 28 August 2026

Market cap

₹20,630.33 cr

24.8 cr shares · Mid cap

Free float

₹12,048.22 cr

as published

P/E · P/B

51.2× · 6.42×

EPS ₹16.26 · BV ₹129.68

FY25-26 rev / PAT

3,473.96 / 400.67

₹ cr, as filed

Filings, window

16

2 selected · 12%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹466.00 52-WK HIGH ₹910.00 ₹832.55 83% of range
Against 52-week high-8.5%
Against 52-week low+78.7%
Day change+0.41%
Size bandMid cap
Index membershipNIFTY 500

Valuation as published by BSE

Earnings per share₹16.26
Price / earnings51.20×
Price / book6.42×
Book value — derived, price ÷ P/B₹129.68
Return on equity12.55%
Operating margin18.11%
Net margin8.95%

Consistency check

P/B ÷ P/E, which must equal ROE
12.54%
ROE as published
12.55%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 801.88 71.75 2.90 18.11% 8.95%
Mar-26 · Q 876.82 98.99 4.04 21.83% 11.29%
FY25-26 3,473.96 400.67 16.48 21.93% 11.53%

Quarter on quarter

Revenue, quarter on quarter
-8.5%
Net profit, quarter on quarter
-27.5%
Operating margin, quarter on quarter
-372 bps

Disclosure profile 16 filings in the window

0 median 17.0 p75 · 24 sector max 59 16 49th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 24 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Change in Management1
Press Release1
Selected sub-total2
Procedural
General5
Analyst / Investor Meet3
AGM / EGM2
SAST2
Allotment1
Trading Window1
Procedural sub-total14
Total16

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 98 trading days

16 filings · 2 selected · busiest 2026-08-06 and 2026-09-11

Filing rhythm · the twelve most recent

2026-08-132026-10-07

SelectedProcedural

Filings

16 in the window · 15 earlier on record

  1. 7 October 2026 ·

    Press Release

    Press Release / Media Release

    Press Release

    Company Update / Press Release / Media Release View filing →

  2. 6 October 2026 ·

    General

    Transcript Of The Webinar

    Transcript of the Webinar held on September 29,2026

    Company Update / General View filing →

  3. 2 October 2026 ·

    General

    Inc orporation Of A Wholly Owned Foreign Subsidiary

    Inc orporation of a Wholly owned foreign Subsidiary

    Company Update / General View filing →

  4. 29 September 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Audio Recording of the Webinar held on September 29, 2026

    Company Update / Analyst / Investor Meet View filing →

  5. 25 September 2026 ·

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Uma Devi Chigurupati

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  6. 25 September 2026 ·

    Trading Window

    Closure of Trading Window

    Closure of Trading Window

    Insider Trading / SAST / Closure of Trading Window View filing →

  7. 23 September 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Schedule of the Analyst/Investor Meeting

    Company Update / Analyst / Investor Meet View filing →

  8. 16 September 2026 ·

    Allotment

    Allotment

    Allotment of equity shares upon conversion of warrants

    Company Update / Allotment of Equity Shares View filing →

  9. 15 September 2026 ·

    General

    Update

    Update

    Company Update / General View filing →

  10. 11 September 2026 ·

    General

    Update

    Update

    Company Update / General View filing →

  11. 11 September 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Schedule of the Analyst/Investor Meeting

    Company Update / Analyst / Investor Meet View filing →

  12. 13 August 2026 ·

    Change in Management

    Change in Management

    Change in Senior Management Personnel (SMP) of the Company

    Company Update / Change in Management View filing →

  13. 6 August 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Scrutinizer's report for the 35th AGM

    AGM/EGM / AGM View filing →

  14. 6 August 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Outcome of 35th Annual General Meeting of the Company

    AGM/EGM / AGM View filing →

  15. 4 August 2026 ·

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  16. 27 July 2026 ·

    General

    Transcript Of The Earnings Call For Q1 Of FY27

    Transcript of the earnings call for Q1 of FY27

    Company Update / General View filing →

RSS feed for Granules India Ltd · the 50 most recent filings